...
首页> 外文期刊>EXCLI Journal >Therapeutic potential of peripheral blood stem cell transplantation in one cirrhotic patient caused by HBV combined with HCV
【24h】

Therapeutic potential of peripheral blood stem cell transplantation in one cirrhotic patient caused by HBV combined with HCV

机译:乙肝合并丙肝引起的肝硬化患者外周血干细胞移植的治疗潜力

获取原文
           

摘要

Stem cell based therapy was very attractive in decompensated liver cirrhosis currently. The possible mechanism might be due to its potential to help tissue regeneration with minimally invasive procedures. Here we report the case of a 44-year-old man, infected by hepatitis B virus (HBV) combined with hepatitis C virus (HCV) for longer than 10 years, who eventually developed decompensated liver cirrhosis. After being infused with mobilized peripheral blood stem cells, the patient showed significantly elevated serum albumin level, cholesterol (CHO), cholinesterase (CHE) and decreased PT (prothrombin time) during the 26 months of follow-up. To our knowledge, this is the first case of transplanting mobilized PBSCs to treat the HBV combined with HCV related decompensated liver cirrhosis.
机译:目前,基于干细胞的疗法在失代偿性肝硬化中非常有吸引力。可能的机制可能是由于其以微创程序帮助组织再生的潜力。在这里,我们报道了一名44岁的男子,感染乙肝病毒(HBV)和丙肝病毒(HCV)的时间超过10年,最终发展为代偿性肝硬化。在输注动员的外周血干细胞后,患者在随访的26个月中显示出血清白蛋白水平,胆固醇(CHO),胆碱酯酶(CHE)明显升高和PT(凝血酶原时间)降低。据我们所知,这是移植动员的PBSC治疗HBV合并HCV相关的失代偿性肝硬化的第一例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号